Cite
MLA Citation
Suchin Virabhak et al.. “Cost-effectiveness of direct-acting antiviral regimen ombitasvir/paritaprevir/ritonavir in treatment-naïve and treatment-experienced patients infected with chronic hepatitis C virus genotype 1b in Japan.” Journal of medical economics, vol. 19, 2017, pp. 1144–1156. http://access.bl.uk/ark:/81055/vdc_100039134383.0x00002f